NOD2 and familial dilated cardiomyopathy: Silencing of NOD2 can ameliorate myocardial apoptosis and fibrosis induced by hyperglycemia in diabetic cardiomyopathy (DCM) mice, thereby presenting a novel potential target for DCM [106].